Pancreatic Safety of Sitagliptin in the TECOS Study

OBJECTIVE: We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i). RESEARCH DESIGN AND METHODS: In the Trial Evaluating Cardiovascular Outcomes w...

Descripción completa

Detalles Bibliográficos
Autores principales: Buse, John B., Bethel, M. Angelyn, Green, Jennifer B., Stevens, Susanna R., Lokhnygina, Yuliya, Aschner, Pablo, Grado, Carlos Raffo, Tankova, Tsvetalina, Wainstein, Julio, Josse, Robert, Lachin, John M., Engel, Samuel S., Patel, Keyur, Peterson, Eric D., Holman, Rury R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864139/
https://www.ncbi.nlm.nih.gov/pubmed/27630212
http://dx.doi.org/10.2337/dc15-2780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864139/
https://www.ncbi.nlm.nih.gov/pubmed/27630212
http://dx.doi.org/10.2337/dc15-2780

Ejemplares similares